Pfizer, Uber and Starbucks Highlight Another Busy Earnings Week
Pfizer Inc., PFE 3.69% Uber UBER -1.15% Technologies Inc. and Starbucks Corp. SBUX 2.13% are among the heavyweights headlining another...
life sciences
Biotech Co-Founder, Facing Murder-for-Hire Charges, Accused of Fabricating Data
Enochian BioSciences Inc. has sued co-founder Serhat Gumrukcu for contractual fraud, alleging that it paid him and his husband $25...
Philips to Cut 4,000 Jobs as Big Recall, Supply Snags Hit Earnings
Royal Philips NV PHG -1.51% said it would cut 4,000 jobs in a bid to turn around its embattled business,...
Drugmakers Look to Limit Medicare’s New Power to Negotiate Lower Drug Prices
Drugmakers are trying to blunt Medicare’s newfound power to negotiate medicine prices while coping with internal industry disputes and ebbing...
Abbott Names New Leadership at Troubled Baby-Formula Plant
Abbott Laboratories has made leadership changes at its major baby-formula manufacturing plant and in its quality organization, following a temporary...
Walgreens Quarterly Sales Fall on Fewer Prescriptions, Covid-19 Vaccinations
Walgreens Boots Alliance Inc. WBA 5.35% said it is counting on its burgeoning healthcare business to fuel profit growth in...
Pfizer’s New Omicron-Targeting Booster Produces Strong Immune Response
The retooled Covid-19 booster from Pfizer Inc. and BioNTech SE generated a strong immune response against the Omicron substrains BA.4...
WSJ News Exclusive | CEO of Biotech Lobbying Group BIO on Leave Amid Clash Over Direction
The chief executive of the biotechnology industry’s top lobbying group in Washington is on leave amid dissent within the organization...
Bayer Hits Courtroom Winning Streak as It Battles Remaining Roundup Lawsuits
Bayer AG BAYRY 3.28% is on a winning streak as it battles the remaining cases targeting its Roundup weedkiller, a...
Walgreens Turns to Prescription-Filling Robots to Free Up Pharmacists
Walgreens WBA 1.56% Boots Alliance Inc. is turning to robots to ease workloads at drugstores as it grapples with a...
Amylyx Prices Newly Approved ALS Drug at $12,500 a Month
The drug, called Relyvrio, was approved by the Food and Drug Administration late Thursday after some staff had raised questions...
Cerebral Treated a 17-Year-Old Without His Parents’ Consent. They Found Out the Day He Died.
Telehealth startup Cerebral Inc. had software that could verify customer IDs but didn’t use it to check birth dates and...
Alzheimer’s Drug Slows Disease Progression in Trial
The pharmaceutical companies said their drug lecanemab reduced cognitive and functional decline by 27%, compared with a placebo, over 18...
Biogen Agrees to Pay $900 Million Over Alleged Improper Physician Payments
Biogen Inc. agreed to pay $900 million to settle allegations that it paid kickbacks to doctors to induce them to...
Unilever CEO to Retire Next Year After Rocky Tenure
LONDON— Unilever UL 1.03% PLC said Chief Executive Officer Alan Jope plans to retire at the end of next year,...
Covid-19 Vaccine Rollout Carries Lessons for Pharma Supply Chains, Says Pfizer Executive
The concentrated effort to develop, manufacture and distribute vaccines as the Covid-19 pandemic began to rage across the world highlighted...
Abbott Faces Competition From Heart Valve Device Cleared by FDA
A new heart valve repair device from Edwards Lifesciences Corp. was as effective as the market-leading device from Abbott Laboratories...
Marijuana Retail Licenses in New York Are Going First to Those Convicted of Drug Crimes
New York regulators want people who were affected by marijuana criminalization to get the first licenses to sell recreational pot...
WSJ News Exclusive | DEA Investigating ADHD Telehealth Provider Done
U.S. Drug Enforcement Administration agents have questioned people about telehealth company Done Global Inc.’s practices for prescribing controlled substances, according...
GE Chief Says Supply Chain Is a Daily Challenge
General Electric Co. GE 2.15% Chief Executive Officer Larry Culp said that the company’s breakup plans are on track but...
